Suppr超能文献

评估血浆蛋白C活性以检测犬肝胆疾病和门体分流。

Evaluation of plasma protein C activity for detection of hepatobiliary disease and portosystemic shunting in dogs.

作者信息

Toulza Olivier, Center Sharon A, Brooks Marjory B, Erb Hollis N, Warner Karen L, Deal Wendy

机构信息

Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA.

出版信息

J Am Vet Med Assoc. 2006 Dec 1;229(11):1761-71. doi: 10.2460/javma.229.11.1761.

Abstract

OBJECTIVE

To determine the diagnostic value of protein C (PC) for detecting hepatobiliary disease and portosystemic shunting (PSS) in dogs.

DESIGN

Prospective study.

ANIMALS

238 clinically ill dogs with (n = 207) and without (31) hepatobiliary disease, including 105 with and 102 without PSS.

PROCEDURES

Enrollment required routine hematologic, serum biochemical, and urine tests; measurement of PC activity; and a definitive diagnosis. Total serum bile acids (TSBA) concentration and coagulation status, including antithrombin activity, were determined in most dogs. Dogs were grouped into hepatobiliary and PSS categories. Specificity and sensitivity were calculated by use of a PC cutoff value of 70% activity.

RESULTS

Specificity for PC activity and TSBA concentrations was similar (76% and 78%, respectively). Best overall sensitivity was detected with TSBA, but PC activity had high sensitivity for detecting PSS and hepatic failure. Protein C activity in microvascular dysplasia (MVD; PC > or = 70% in 95% of dogs) helped differentiate MVD from portosystemic vascular anomalies (PSVA; PC < 70% in 88% of dogs). A receiver operating characteristic curve (PSVA vs MVD) validated a useful cutoff value of < 70% activity for PC.

CONCLUSIONS AND CLINICAL RELEVANCE

Combining PC with routine tests improved recognition of PSS, hepatic failure, and severe hepatobiliary disease and signified a grave prognosis when coupled with hyperbilirubinemia and low antithrombin activity in hepatic failure. Protein C activity can help prioritize tests used to distinguish PSVA from MVD and sensitively reflects improved hepatic-portal perfusion after PSVA ligation.

摘要

目的

确定蛋白C(PC)对检测犬肝胆疾病和门体分流(PSS)的诊断价值。

设计

前瞻性研究。

动物

238只临床患病犬,其中207只患有肝胆疾病,31只未患肝胆疾病,包括105只患有PSS和102只未患PSS。

方法

入组需要进行常规血液学、血清生化和尿液检测;测量PC活性;以及明确诊断。大多数犬测定了总血清胆汁酸(TSBA)浓度和凝血状态,包括抗凝血酶活性。犬被分为肝胆疾病组和PSS组。使用PC活性临界值70%计算特异性和敏感性。

结果

PC活性和TSBA浓度的特异性相似(分别为76%和78%)。TSBA检测到的总体敏感性最佳,但PC活性对检测PSS和肝衰竭具有高敏感性。微血管发育异常(MVD)中的蛋白C活性(95%的犬PC≥70%)有助于将MVD与门体血管异常(PSVA;88%的犬PC<70%)区分开来。受试者工作特征曲线(PSVA与MVD)验证了PC活性<70%的有用临界值。

结论及临床意义

将PC与常规检测相结合可提高对PSS、肝衰竭和严重肝胆疾病的识别,并且在肝衰竭伴有高胆红素血症和低抗凝血酶活性时预示预后不良。蛋白C活性有助于优先进行用于区分PSVA与MVD的检测,并敏感地反映PSVA结扎后肝门静脉灌注的改善情况。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验